Balance Sheet Data

Anika Therapeutics, Inc. (ANIK)

$24.25

+0.04 (+0.17%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 159.01184.9498.3294.3986.33174.65192.73212.68234.69258.99
Total Cash (%)
Account Receivables 20.7823.0824.1029.8434.6334.7138.3042.2646.6451.47
Account Receivables (%)
Inventories 21.3021.9946.2136.0139.7742.9747.4152.3257.7463.72
Inventories (%)
Accounts Payable 3.143.838.987.639.078.349.2010.1511.2012.36
Accounts Payable (%)
Capital Expenditure -4.66-2.83-1.63-5.14-7.49-5.65-6.24-6.89-7.60-8.38
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.